Diet and chronic renal failure: Is 'Self-Sustaining progression' in terminal decline?

Journal of Nutritional and Environmental Medicine

Volumn 9, Issue 1, 1999, Pages 63-76

  Michell, A R ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Chronic renal failure; Dietary protein; Glomerular filtration rate; Glomerular hypertension; Hyperfiltration; Hypertension; Nephrosclerosis; Phosphate; Progression; Single nephron glomerular filtration rate

Indexed keywords

CALCIUM; LIPID; PARATHYROID HORMONE; PHOSPHATE; PROTEIN;

ANIMAL MODEL; CHRONIC KIDNEY FAILURE; DIET; DISEASE COURSE; DOG; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; METABOLIC ACIDOSIS; NEPHROLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENOVASCULAR HYPERTENSION; REVIEW; ULTRAFILTRATION;

ANIMALIA; CANIS FAMILIARIS; GLOMERULUS;

EID: 0033038803     PISSN: 13590847     EISSN: None     Source Type: Journal    
DOI: 10.1080/13590849961852     Document Type: Review

References (118)

1. [1] Hostetter JH. Editorial. J Lab Clin Med 1987; 109: 375-77.
2. [2] Bricker NS. On the meaning of the intact nephron hypotheses. Am J Med 1969; 46: 1-7.
3. [3] Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985; 249F: 324-7.
4. [4] Ridson RA, Sloper JC, de Wardener HE. Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerulonephritis. Lancet 1968; ii: 363-5.
5. [5] Brunskill N, Klahr S. Mechanisms of renal failure. In: El Nahas AM, Mallick NP, Anderson S, (Eds). Prevention of Progressive Chronic Renal Failure. Oxford: Oxford University Press, 1993: 1-61.
6. [6] Nath K. The role of tubulointerstitial processes in progressive renal disease. In: El Nahas AM, Mallick NP, Anderson S, (Eds). Prevention of Progressive Chronic Renal Failure. Oxford: Oxford University Press, 1993: 1-61; 62-97.
7. [7] Michell AR. Renal Disease in Dogs and Cats; Comparative and Clinical Aspects, Oxford: Blackwell Scientific, 1988: 1-3; 5-29.
8. [8] Solomon R. Radiocontrast-induced nephropathy. Sem Nephrol 1998; 18: 551-7.
9. [9] Gleadhill A, Michel AR. Evaluation of iohexol as a marker for the clinical measurement of glomerular filtration rate in dogs. Res Vet Sci, 1996; 60: 117-21.
10. [10] Heine R, Moe L. Pharmacokinetic aspects of measurement of glomerular filtration rate in the dog: a review. J Vet Int Med 1998; 12: 401-14.
11. [11] Kasiske BL, Keane WF. Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy. In: Brenner BM, (Ed). The Kidney (5th Edn) Philadelphia, PA: WB Saunders, 1996: 1137-74.
12. [12] Gleadhill A, Michell AR. Clinical measurement of renal function. In: Bainbridge J and Elliott J, (Ed). Manual of Canine and Feline Nephrology and Urology. Cheltenham: BSAVA, 1996: 107-16.
13. [13] Laville M, Hadj-Aissa, Pozet N, Le Bras JH, Labeeuw M, Zech P. Glomerulotubular responses to acute protein load: changes in creatinine and sodium handling. Kidney Int 1989; 36 (Suppl 27): S59-S63.
14. [14] Flynne FV. Assessment of renal function: selected developments. Clin Biochem 1990; 23: 49-54.
15. [15] Levey AS. Measurement of renal function in chronic renal disease. Kidney Int 1990; 38: 167-84.
16. [16] Perrone RD. Means of clinical evaluation of renal disease progression. Kidney Int 1992; 41 (Suppl 36): S26-S32.
17. [17] Williams PS, Mallick NP. The natural history of chronic renal failure. In: El Nahas AM, Mallick NP, Anderson S, (Eds). Prevention of Progressive Chronic Renal Failure. Oxford: Oxford University Press, 1993; 210-54.
18. [18] Ferraro F, Rastaldi MP. Pathology of rapidly progressive glomerulonephritis. In: Pusey C, Rees A, (Eds). Rapidly Progressive Glomerulonephritis. Oxford: Oxford Medical Publications, 1998: 59-107.
19. [19] Allen TA, Jaenke RS, Fettman MJ. A technique for estimating progression of chronic renal failure in the dog. J Am Vet Med Assoc, 1987; 190: 866-8.
20. [20] Brown SA, Crowell WA, Brown CA, Barsanti JA, Finco DR. Pathophysiology and management of progressive renal disease. 1997; 154: 93-109.
21. [21] Michell AR. The Clinical Biology of Sodium. Oxford: Pergamon, 1995.
22. [22] Michell AR. Progression of chronic renal failure: have we progressed? Vet Ann 1995; 35: 159-76.
23. [23] Shapiro JI, Elkins N, Reiss OK, et al. Energy metabolism following reduction of renal mass. Kidney Int 1994; (45 Suppl. 45): S100-5.
24. [24] Lafferty HM, Brenner BM. Are glomerular hypertension and hypertrophy independent risk factors for progression of renal disease? Semin Nephrol 1990; 10: 294-304.
25. [25] Viberti GC. Natural history and treatment of diabetic nephropathy. In: Oldrizzi L, Maschio G, Rugiv C, Campese VM, (Eds). The Progressive Nature of Renal Disease: Myths and Facts. Basel: Karger, 1989: 117-26.
26. [26] Molitoris BA. The potential role of ischaemia in renal disease progression. Kidney Int 1992; 41 (Suppl 36): S21-5.
27. [27] Mitch WE. Nutritional influences as changes in kidney growth and function and the responses to kidney diseases. Semin Nephrol 1993; 13: 503-7.
28. 3 metabolites and alkali agents in predialysis patients. Semin Nephrol 1997; 17: 270-84.
29. [29] Clark EC, Nath KA, Hostetter MK, Hostetter TH. Role of ammonia in progressive interstitial nephritis. Am J Kidney Dis 1991; 17 (Suppl 1): 15-9.
30. [30] Nath KA, Clark EC, Hostetter MK, Hostetter TH. Ammonia, Complement, Tubulointerstitial Damage. Proceedings of the XIIth International Congress of Nephrology (Jerusalem); 1993: p. 15.
31. [31] Nath KA, Fischereder M, Hostetter TH. Role of oxidants in progressive renal injury. Kidney Int 1994; 54 (Suppl 45): S111-5.
32. [32] Price SR, Mitch WE. Metabolic acidosis and uraemic toxicity: protein and amino acid metabolism. Semin Nephrol 1994; 14: 232-7.
33. [33] Vanholder R, De Smet R, Hsu C, Vogeleere P, Ringoir S. Uremic toxicity: the middle molecule hypothesis revisited. Semin Nephrol 1994; 14: 205-8.
34. [34] Massry, Smogorzewski M. Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia. Semin Nephrol 1994; 14: 219-31.
35. [35] Kramer HJ, Meyer-Lehnert H, Mohaupt M. Role of calcium in the progression of chronic renal disease: experimental evidence. Kidney Int 1992; 41 (Suppl 36) S2-7.
36. [36] Combe C, Aparicio M. Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int 1994; 16: 1381-6.
37. [37] Finco DR, Brown SA, Crowell WA, Duncan RJ, Barsanti JA, Bennett SE. Effect of dietary phosphorus and protein in dogs with chronic renal failure. Am J Vet Res 1992; 53: 2264-71.
38. [38] Finco DR, Brown SA, Crowell WA. Effects of dietary protein and phosphorus on the kidneys of dogs. In: Carey DP, Norton BA, Bolser SM, (Eds). Recent Advances in Canine and Feline Nutritional Research. Wilimington, Ohio: Orange Fraser Press, 1996: 123-42.
39. [39] Plante GE. Urinary phosphate excretion determines the progression of renal disease. Kidney Int 1989; 36 (Suppl 27): S128-32.
40. [40] El Nahas AM. Hypertension and glomerular sclerosis: where, when and how? In: Klinkmann H, Smeby LC, (Eds). Terminal Renal Failure: Therapeutic Problems. Basel: Karger, 1990: 71-2.
41. [41] Neuringer JR, Levey AS. Strategies to slow progression of renal disease. Semin Nephrol 1994; 14: 261-73.
42. [42] Kes P, Ratkovic-Gusic I. The role of arterial hypertension in progression of renal failure. Kidney Int 1996; 55 (Suppl): S72-4.
43. [43] Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end stage renal disease in men. N Engl J Med, 1996; 334: 13-8.
44. [44] Campese VM, Liu L. Antihypertensive therapy and progression of renal failure. In: Oldrizzi L, Maschio G, Rugiv C, Compese VM, (Eds). The Progressive Nature of Renal Disease: Myths and Facts. Basel: Karger, 1989: 155-66.
45. [45] Freedman BI, Iskandar SS, Appel RG. The link between hypertension and nephrosclerosis. Am J Kid Dis 1995; 25: 207-21.
46. [46] Bjork B, Multee H, Johnsen SA, Norden G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ 1992; 304: 339-43.
47. [47] Wolf G, Neilson EG. Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells. Kidney Int 1993; 43: S100-7.
48. [48] El Nahas AM. Glomerulosclerosis: insights into pathogenesis and treatment. Nephrol Dial Transplant, 1989; 4: 843-53.
49. [49] Ihle BV, Whitworth JA, Shahintar S, Cnaan A, Kincaid-Smith PS, Becker GJ. Angiotensin converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial. Am J Kidney Dis 1996; 27: 489-95.
50. [50] Brown SA, Walton CL, Crawford P, Bakris GL. Long-term effects of antihypertensive regimes on renal hemodynamics and proteinuria. Kidney Int 1993; 43: 1210-7.
51. [51] Kramer HJ, Meyer-Lehnert H, Mohaupt M. Role of calcium in the progression of renal disease: experimental evidence. Kidney Int 1992; 41 (Suppl 36): S2-7.
52. [52] Carmines PK, Mitchell KD, Navar LG. Effects of calcium antagonists on renal hemodynamics and glomerular function. Kidney Int 1992; 41 (Suppl 36): S43-8.
53. [53] Zuchelli P, Zuccala A, Gaggi R. Calcium channel blockers: effects on progressive renal disease. Am J Kidney Dis 1991; 17 (Suppl 1): 94-7.
54. [54] Epstein M. Calcium antagonists and the kidney: implications for renal protection. Kidney Int 1992; 41 (Suppl 36): S66-72.
55. [55] Kloke HJ, Branter AJ, Huysmans FT, Wetzeki JK. Antihypertensive treatment of patients with proteinuric renal diseases; risks or benefits of calcium channel blockers. Kidney Int 1998; 53: 1559-73.
56. [56] Kilaru PK, Bakric GL. Calcium channel blockade and/or ACE inhibition for prevention of diabetic and hypertensive nephropathy. In: Opic LH, Messerli, FH, (Eds). Combination Drug Therapy for Hypertension. New York: Lippincott-Raven, 1997: 123-38.
57. [57] Miles AM, Friedman EA. Strategies for slowing progression of diabetic nephropathy. In: Andrews VE, Fine LG, (Eds). International Year Book of Nephrology. London: Springer-Verlag, 1993: 109-39.
58. [58] Walker JD, Viberti GC. Aetiology and pathogenesis of diabetic nephropathy: clues from early functional abnormalities. In: Pickup JC, Williams G, (Eds). Chronic Complications of Diabetes. Oxford: Blackwell Scientific 1994: 146-61.
59. [59] Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996; 27: 765-7.
60. [60] Benigni A, Remuzzi G. Glomerular protein trafficking and progression of renal disease to terminal uremia. Semin Nephrol 1996; 16: 151-9.
61. [61] D'Amico G. The clinical role of proteinuria. Am J Kidney Dis 1991; 17 (Suppl 1): 48-92.
62. [62] Bertani T. Altered permeability to protein. Proceedings of the XIIth International Congress of Nephrology (Jerusalem) 1993; 16.
63. [63] Ofstad J, Harvei G, Kuam FI et al. Glomerular hemodynamics in progressive renal disease. Kidney Int 1992; 4 (Suppl 36): S8-14.
64. [64] Cortes P, Riser BL, Zhao X, Narins RG. Glomerular volume expansion and mesangial cell mechanical strain: mediators of glomerular pressure injury. Kidney Int 1994; 45 (Suppl 45): S11-6.
65. [65] Shultz PJ, Raj L. The glomerular mesangium: role in initiation and progression of renal injury. Am J Kidney Dis 1991; 17 (Suppl 1): 8-14.
66. [66] Rennke HG. How does glomerular epithelial injury contribute to progressive glomerular damage? Kidney Int 1994; 45 (Suppl 45): S58-63.
67. [67] Kriz Elger M, Nagata M, et al. The role of podocytes in the development of glomerular sclerosis. Kidney Int 1994; 45 (Suppl 45): S64-72.
68. [68] Remuzzi A, Remuzzi G. The effects of nonsteroidal anti-inflammatory drugs on glomerular filtration of proteins and their therapeutic utility. Semin Nephrol 1995; 15:236-43.
69. [69] Peters H, Noble NA. Dietary L-arginine in renal disease Semin Nephrol 1996; 16: 567-75.
70. [70] Herrera-Acosta J. The role of systemic and glomerular hypertension in progressive glomerular injury. Kidney Int 1994; 45 (Suppl 45): S6-10.
71. [71] Lafferty HM, Brenner BM. Are glomerular hypertension and hypertrophy independent risk factors for progression of renal disease? Semin Nephrol 1990; 10: 294-304.
72. [72] Bovee KC. High dietary protein intake does not cause progressive renal failure in dogs after 75% nephrectomy or ageing. Semin Vet Med Surg (Small Anim) 1992; 7: 227-36.
73. [73] Klahr S, Harris K. Role of dietary lipids and renal cicosanoids on the progression of renal disease. Kidney Int 1989; 36 Suppl 27): S27-31.
74. [74] Schmitz PG, Kasiske BL, O'Donnell MP, Keane WF. Lipids and progressive renal injury. Semin Nephrol 1989; 9: 354-69.
75. [75] Schreiner GF. Dietary management of immunologically-mediated renal disease. Kidney Int 1991; 39 (Suppl 31): S49-56.
76. [76] Moorhead JF. Lipids in the pathogenesis of kidney disease. Am J Kidney Dis 1991; 17 (Suppl 1): 65-70.
77. [77] Anderson S, Kennefick TM, Brenner BM. Renal and systemic manifestations of glomerular disease. In: Brenner BM, (Ed). The Kidney (5th Edn). Philadelphia, PA: WB Saunders, 1996: 1996-2000.
78. [78] Mittman N, Avram MM. Dyslipidemia in renal disease. Semin Nephrol 1996; 16: 202-13.
79. [79] Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Ncphrol Dial Transplant 1997; 12: 1908-15.
80. [80] Monzani G, Bergesio F, Ciuti R, Ciciani AM, Martinelli F, Rosati A, Salvadori M. Lp(a) levels: effect of progressive chronic renal failure and dietary manipulation. J Nephrol 1997; 10: 41-5.
81. [81] Brown SA, Finco DR. Fatty acid supplementation and chronic renal disease. In: Carey DP, Norton SA, Bolser SM, (Eds). Recent Advances in Canine and Feline Nutritional Research. Wilmington, OH: Orange Frazer Press, 1996: 159-70.
82. [82] Brown SA, Brown CA, Crowell WA, Barsanti JA, Finco DR. Does modifying dietary lipids influence progression of renal failure? Vet Clin North Am Small Anim Pract 1996; 1277-85.
83. [83] Capelli P, Di Liberato L, Sturd S, Ballone E, Albertazzi A. N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease. J Nephrol 1997; 10: 157-62.
84. [84] Brown SA. Influence of dietary fatty acids on intrarenal hypertension. In: Reinhart GA, Carey DP, (Eds). Recent Advances in Canine and Feline Nutrition. Wilmington, OH: Orange Frazer Press, 1998: 405-11.
85. [85] Tapp DC, Kobayashi F, Fernandes G, Venkatachalam MA. Protein restriction or calorie restriction? A critical assessment of the influence of selective calorie restriction on the progression of experimental renal disease. Semin Nephrol 1989; 9: 343-53.
86. [86] Narins RG, Cortes P. The role of dietary protein restriction in progressive azotemia. N Engl J Med 1994; 330: 929-30.
87. [87] Modi KS, O'Donnell MP, Keane WF. Dietary intervention for progressive renal disease in experimental animal models. In: El Nahas AM, Mallick NP, Anderson S, (Eds). Prevention of Progressive Chronic Renal Failure. Oxford: Oxford University Press, 1993: 117-72.
88. [88] Descamps-Latscha B, Herbelin A, Nguyen AT, Zingraff J, Jungers P, Chatenoud L. Immune system dysregulation in uremia. Semin Nephrol 1994; 14: 253-60.
89. [89] Niwa T. Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure. Semin Nephrol 1996; 16: 167-82.
90. [90] Niwa T, Nomura T, Sugiyana S, Miyazaki T, Tsukushi S, Tsutsui S. The protein metabolite hypothesis, a model for the progression of renal failure; an oral adsorbent lowers indoxyl sulphate levels in undialyzed uremic patients. Kidney Int 1997; 62: S23-8.
91. [91] Hannedouche T, Chauveau P, Fehrat A, Albouze G, Jungers P. Effect of moderate protein restriction on the rate of progression of chronic renal failure. Kidney Int 1989; 36 (Suppl 27): S91-5.
92. [92] Rosman JB, Langer K, Brandl M, Piers-Becht T, Ph-M, Crjalt K, Van der Hem, ter Wee PM, Donker Ab JM. Protein restricted diets in chronic renal failure: a four year follow up shows limited indications. Kidney Int 1989; 36 (Suppl 27): S96-102.
93. [93] Ihle BV, Becker GJ, Whitworth JA, Charlwood RA, Kincaid Smith P. The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 1989; 321: 1773-7.
94. [94] Holm EA, Solling K. Dietary protein restriction and the progression of chronic renal insufficiency: a review of the literature. J Int Med 1996; 239: 99-104.
95. [95] Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PG. The effect of dietary protein on the progression of diabetic and non-diabetic renal diseases; a meta-analysis. Ann Intern Med 1996; 124: 627-32.
96. [96] Winger AM, Fabian-Back C, Schaefer F, Mehls O. Randomized multicentre study of a low protein diet on the progression of chronic renal failure in children. Lancet 1997; 349: 1117-23.
97. [97] Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 878-84.
98. [98] Klahr S. Role of dietary protein and blood pressure in the progression of renal disease. Kidney Int 1996; 49: 1783-6.
99. [99] Striker GE, Klahr S. Clinical trials in progression of chronic renal failure. Adv Int Med 1997; 42: 555-95.
100. [100] Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 878-84.
101. [101] Polzin DJ, Leininger JL, Osborne CA. Chronic progressive renal failure: can progression be modified? In: Michell AR, (Ed). Renal Disease in Dogs and Cats; Comparative and Clinical Aspects. Oxford: Blackwell Scientific, 1988; 129-44.
102. [102] Valli VEO, Bacemal R, Thorner P, et al. Dietary modification reduces splitting of glomerular basement membrane and delays death due to renal failure in canine x-linked hereditary nephritis. Lab Invest 1991; 65: 67-73.
103. [103] Kronfeld DS. Dietary management of chronic renal failure in dogs: a critical appraisal. J Small Anim Pract 1993; 34: 211-9.
104. [104] Carey DP. Clinical assessment of chronic renal failure. In Reinhart GA, Carey DP, (Eds). Recent Advances in Canine and Feline Nutrition. Wilmington, OH: Orange Frazer Press, 1998; 381-94.
105. [105] Elliott J, Barber PJ. Feline chronic renal failure: clinical findings in 80 cases diagnosed between 1992 and 1995. J Small Anim Pract 1998; 39: 78-86.
106. [106] Michell AR. Management of renal disease - have we progressed? Proceedings of the 4th FECAVA Congress (Bologna) Federation of European Companion Animal Associations 1998; 289-93.
107. [107] Dow SW, Fettman MJ, Le Couteur RA, Hamar DW. Potassium depletion in cats: renal and dietary influences. J Am Vet Med Assoc 1987; 191: 1569-75.
108. [108] DiBartola SP, de Morais HSA. Disorders of potassium: hypokalemia and hyperkalemia. In: DiBartola SP, (Ed). Fluid Therapy in Small Animal Practice, Philadelphia, PA: WB Saunders, 1992: 89-115.
109. [109] Finco DR, Brown SA, Brown CA, Crowell WA, Sunvold GD, Cooper TA. Influence of protein and energy in cats with renal failure. In: Reinhart GA, Carey DP, (Eds). Recent Advances in Canine and Feline Nutrition. Wilmington, OH: Orange Frazer Press, 1998: 413-24.
110. [110] Bourgoignie JJ, Gavelles G, Hwang KH, Disbrow MR, Sabnis SG, Antonovych TT. Renal function of baboons with a remnant kidney and impact of different protein diets. Kidney Int 1989; 36 (Suppl 27): S86-90.
111. [111] Bourgoignie JJ, Gavelles G, Martinez G, Pardo V. Glomerular function and morphology after renal mass reduction in dogs. Lab Clin Med 1987; 109: 380-8.
112. [112] Novick AC, Gephardt G, Guz B, Steinmuller D, Tubbs R. Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 1991; 325: 1058-62.
113. [113] Fine LG. How little kidney tissue is enough? N Engl J Med, 1991; 325: 1097-9.
114. [114] Hunsicker LG. Studies of therapy of progressive renal failure in humans. Semin Nephrol 1989; 9: 380-94.
115. [115] Walser MW, Drew HH, La France ND. Reciprocal creatinine slopes often give erroneous estimates of progression of chronic renal failure. Kidney Int 1989; 36 (Suppl 27): S81-5.
116. [116] Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-62.
117. [117] Levey AS. Assessing the effectiveness of therapy to prevent the progression of renal disease. Am J Kidney Dis 1993; 22: 207-14.
118. [118] Shapiro JI, Elkins N, Reiss OK, Suleymanlar G, Jin H, Schrier RW, Chan L. Energy metabolism following reduction of renal mass. Kidney Int 1994; 45 (Suppl 45): S100-5.